Earlier this month, EOFlow, an emerging medical device company with offices in Seoul, South Korea and San Jose, Californ…
Products & Tech
FDA Rejects Sanofi-Lexicon Oral Medication for Type 1 Diabetes
The FDA has denied approval of Sanofi and Lexicon’s drug, sotagliflozin, as an add-on to insulin therapy in the tr…
Tandem’s Control-IQ Explained
Last fall, I wrote about how glad my husband and I were that our daughter, Bisi, had pushed to switch to the t:slim X2 …
Lilly to Introduce Lispro, a Lower-Priced Authorized Generic Humalog
Eli Lilly and Company has announced it would introduce a lower-priced version of Humalog® (insulin lispro injection 100 …
Tandem’s X2 Insulin Pump Is First Device to Receive New FDA ACE Pump Classification
Tandem Diabetes Care, Inc. announced that the U.S. FDA has classified the t:slim X2 insulin pump as the first in a new d…
Why Do Long and Short Acting Insulin Pens Look Nearly Identical?
On the top Tresiba long-acting basal insulin, in the middle old Fiasp and on the bottom new Fiasp ultra-rapid insulin
…
8 Reasons Why Insulin is so Outrageously Expensive
This story was co-written by James Elliott and Elizabeth Pfiester. It originally appeared on T1International.
Why does …
10 Things to Look for in Diabetes Tech and Drugs in 2019
The coming year promises to be a busy one for innovations in diabetes tech and medicine. Here are ten things currently i…
The Perfect Holiday Gift Guide for People with Diabetes
Sponsored by Diathrive
From practical and useful everyday gifts to more luxurious items, there’s something for eve…
Metformin Can Protect the Hearts of People with Diabetes
Metformin protects the hearts of people with Type 1 diabetes, according to the results of the MERIT clinical trial. Metf…